Your browser doesn't support javascript.
loading
The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.
Venkatesulu, Bhanu Prasad; Thoguluva Chandrasekar, Viveksandeep; Giridhar, Prashanth; V, Pragathee; Patel, Harsh K; Manteuffel, Jacob.
Affiliation
  • Venkatesulu BP; Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.
  • Thoguluva Chandrasekar V; Department of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas.
  • Giridhar P; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • V P; Department of Internal Medicine, Karpagam Faculty of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.
  • Patel HK; Department of Internal Medicine, Ochsner Medical Center, New Orleans, Louisiana.
  • Manteuffel J; Department of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan.
J Med Virol ; 93(2): 843-853, 2021 02.
Article in En | MEDLINE | ID: mdl-32706390
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Endpoint Determination / COVID-19 / COVID-19 Drug Treatment Type of study: Systematic_reviews Limits: Humans Country/Region as subject: America do norte / Asia Language: En Journal: J Med Virol Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Endpoint Determination / COVID-19 / COVID-19 Drug Treatment Type of study: Systematic_reviews Limits: Humans Country/Region as subject: America do norte / Asia Language: En Journal: J Med Virol Year: 2021 Type: Article